110
Views
9
CrossRef citations to date
0
Altmetric
Research Article

p-Cresol inhibits IL-12 production by murine macrophages stimulated with bacterial immunostimulant

, , , &
Pages 304-309 | Received 27 Oct 2008, Accepted 10 Dec 2008, Published online: 01 Jun 2009

References

  • Curtius, HC.; Mettler, M.; Ettlinger, L. Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry. J Chromatogr. 1976, 126:569–580.
  • Cummings, JH.; Hill, MJ.; Bone, ES.; Branch, WJ.; Jenkins, DJ. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr. 1979, 32:2094–2101.
  • Bakke, OM. Urinary simple phenols in rats fed diets containing different amounts of casein and 10% tyrosine. J Nutr. 1969, 98:217–221.
  • Evenepoel, P.; Claus, D.; Geypens, B.; Hiele, M.; Geboes, K.; Rutgeerts, P.; Ghoos, Y. Amount and fate of egg protein escaping assimilation in the small intestine of humans. Am J Physiol. 1999, 277:G935–43.
  • Bammens, B.; Verbeke, K.; Vanrenterghem, Y.; Evenepoel, P. Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int. 2003, 64:2196–2203.
  • De Smet, R.; David, F.; Sandra, P.; Van Kaer, J.; Lesaffer, G.; Dhondt, A.; Lameire, N.; Vanholder, R. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta. 1998, 278:1–21.
  • Hida, M.; Aiba, Y.; Sawamura, S.; Suzuki, N.; Satoh, T.; Koga, Y. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin®, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron. 1996, 74:349–355.
  • Wardle, EN. A study of the effects of possible toxic metabolites of uraemia on red cell metabolism. Acta Haematol. 1970, 43:129–143.
  • Müting, D. Studies on the pathogenesis of uremia. Comparative determinations of glucuronic acid, indican, free and bound phenols in the serum, cerebrospinal fluid, and urine of renal diseases with and without uremia. Clin Chim Acta. 1965, 12:551–554.
  • Rabiner, SF.; Molinas, F. The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med. 1970, 49:346–351.
  • Bloembergen, WE.; Stannard, DC.; Port, FK.; Wolfe, RA.; Pugh, JA.; Jones, CA.; Greer, JW.; Golper, TA.; Held, PJ. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int. 1996, 50:557–565.
  • Allon, M.; Depner, TA.; Radeva, M.; Bailey, J.; Beddhu, S.; Butterly, D.; Coyne, DW.; Gassman, JJ.; Kaufman, AM.; Kaysen, GA.; Lewis, JA.; Schwab, SJ, HEMO Study Group. Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO Study. J Am Soc Nephrol. 2003, 14:1863–1870.
  • Vanholder, R.; Van Loo, A.; Dhondt, AM.; De Smet, R.; Ringoir, S. Influence of uraemia and haemodialysis on host defense and infection. Nephrol Dial Transplant. 1996, 11:593–598.
  • Vanholder, R.; De Smet, R.; Waterloos, MA.; Van Landschoot, N.; Vogeleere, P.; Hoste, E.; Ringoir, S. Mechanisms of uremic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol. Kidney Int. 1995, 47:510–517.
  • Wratten, ML.; Tetta, C.; De Smet, R.; Neri, R.; Sereni, L.; Camussi, G.; Vanholder, R. Uremic ultrafiltrate inhibits platelet-activating factor synthesis. Blood Purif. 1999, 17:134–141.
  • Faure, V.; Cerini, C.; Paul, P.; Berland, Y.; Dignat-George, F.; Brunet, P. The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. Int Immunol. 2006, 18:1453–1459.
  • Bammens, B.; Evenepoel, P.; Keuleers, H.; Verbeke, K.; Vanrenterghem, Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 2006, 69:1081–1087.
  • De Smet, R.; Van Kaer, J.; Van Vlem, B.; De Cubber, A.; Brunet, P.; Lameire, N.; Vanholder, R. Toxicity of free p-cresol: A prospective and cross-sectional analysis. Clin Chem. 2003, 49:470–478.
  • Trinchieri, G. Interleukin-12: A cytokine at the interface of inflammation and immunity. Adv Immunol. 1998, 70:83–243.
  • Trinchieri, G. Immunobiology of interleukin-12. Immunol Res. 1998, 17:269–278.
  • Shida, K.; Kiyoshima-Shibata, J.; Nagaoka, M.; Watanabe, K.; Nanno, M. Induction of interleukin-12 by lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J Dairy Sci. 2006, 89:3306–3317.
  • Shida, K.; Suzuki, T.; Kiyoshima-Shibata, J.; Shimada, S.; Nanno, M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol. 2006, 13:997–1003.
  • Kato, I.; Tanaka, K.; Yokokura, T. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int J Immunopharmacol. 1999, 21:121–131.
  • de Loor, H.; Bammens, B.; Evenepoel, P.; De Preter, V.; Verbeke, K. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem. 2005, 51:1535–1538.
  • Tlaskalová-Hogenová, H.; Stepánková, R.; Hudcovic, T.; Tucková, L.; Cukrowska, B.; Lodinová-Zádníková, R.; Kozáková, H.; Rossmann, P.; Bártová, J.; Sokol, D.; Funda, DP.; Borovská, D.; Reháková, Z.; Sinkora, J.; Hofman, J.; Drastich, P.; Kokesová, A. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004, 93:97–108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.